Triazole macrocycle systems

US2016289274A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016289274-A1
Application numberUS-201615093426-A
CountryUS
Kind codeA1
Filing dateApr 7, 2016
Priority dateFeb 23, 2007
Publication dateOct 6, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.

First claim

Opening claim text (preview).

1 - 77 . (canceled) 78 . A method of synthesizing a peptidomimetic macrocycle, the method comprising: (a) synthesizing a peptide that incorporates: (i) an alkyne moiety; and (ii) an amino acid moiety of the formula: wherein: R 2 is —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkylalkyl, heteroalkyl, or heterocycloalkyl, unsubstituted or substituted with halo-; each Q and T is independently selected from the group consisting of alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and [—R 4 —K—R 4 —] n , each of which is unsubstituted or substituted with R 5 ; each K is independently O, S, SO, SO 2 , CO, CO 2 , or CONR 3 ; each R 3 is independently hydrogen, alkyl, alkenyl, alkynyl, arylalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, cycloalkylalkyl, cycloaryl, or heterocycloaryl, optionally substituted with R 5 ; each R 4 is independently alkylene, alkenylene, alkynylene, heteroalkylene, cycloalkylene, heterocycloalkylene, arylene, or heteroarylene; each R 5 is independently halogen, alkyl, —OR 6 , —N(R 6 ) 2 , —SR 6 , —SOR 6 , —SO 2 R 6 , —CO 2 R 6 , a fluorescent moiety, a radioisotope or a therapeutic agent; each R 6 is independently —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkylalkyl, heterocycloalkyl, a fluorescent moiety, a radioisotope or a therapeutic agent; R 8 is —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkylalkyl, heteroalkylalkyl, or heterocycloalkyl; R 10 and R 11 are independently —H or any protecting group suitable for peptide synthesis; g and h are each independently an integer from 0 to 5; n is an integer from 1 to 5; and (b) macrocyclizing the peptide. 79 . The method of claim 78 , wherein the peptidomimetic macrocycle comprises an additional macrocycle. 80 . The method of claim 78 , wherein R 2 is hydrogen. 81 . The method of claim 78 , wherein R 2 is methyl. 82 . The method of claim 78 , wherein the peptidomimetic macrocycle comprises an α-helix. 83 . The method of claim 82 , wherein the α-helix comprises from 1 turn to 5 turns. 84 . The method of claim 78 , wherein the peptidomimetic macrocycle comprises a ring of about 29 atoms to about 37 atoms. 85 . The method of claim 78 , wherein the method is performed in solution. 86 . The method of claim 78 , wherein the method is performed on a solid support. 87 . The method of claim 78 , wherein the peptidomimetic macrocycle comprises two macrocycle-forming linkers. 88 . The method of claim 87 , wherein the length of one of the macrocycle-forming linkers spans about 1 turn of a secondary structure of the peptidomimetic macrocycle. 89 . The method of claim 87 , wherein the length of one of the macrocycle-forming linkers is about equal to the length of from about 6 carbon-carbon bonds to about 14 carbon-carbon bonds. 90 . The method of claim 87 , wherein the length of one of the macrocycle-forming linkers is about equal to the length of from about 8 carbon-carbon bonds to about 12 carbon-carbon bonds. 91 . The method of claim 87 , wherein the peptidomimetic macrocycle comprises a ring of about 18 atoms to 26 atoms.

Assignees

Inventors

Classifications

  • Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof · CPC title

  • C07K1/006Primary

    of peptides containing derivatised side chain amino acids · CPC title

  • C07K7/06Primary

    having 5 to 11 amino acids · CPC title

  • by covalent attachment of amino acids or peptide residues · CPC title

  • the cyclisation not occurring through 2,4-diamino-butanoic acid · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016289274A1 cover?
The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Who is the assignee on this patent?
Aileron Therapeutics Inc
What technology area does this patent fall under?
Primary CPC classification C07K1/006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).